Shingrix®

Herpes zoster is caused by the same virus that causes chickenpox in children. When this virus becomes active again in an adult, it can cause herpes zoster, or shingles. Shingrix® is the new shingles vaccine which was FDA approved in October 2017 and will be available in early 2018. Shingrix® completely replaces Zostavax® Zostavax® is a live virus vaccine and cannot be given to people who have compromised immune systems because of cancer or drugs such as Humira® Zostavax® reduced the risk of shingles by a maximum of 51% at the time it is given and this protection diminishes over time and is 0% at 5 years. Zostavax® is less effective in people over 60 and provides relatively little protection in people in their 80s. Shingrix® is not a live vaccine and may be given to almost anyone regardless of their immune status or medications. Shingrix® provides 90-95% protection to people as old as 90 and this protection is still 88% after 4 years. The CDC recommends Shingrix® for everyone over 50 years of age even if they have previously received Zostavax®

The older you are the more likely you are to develop shingles and the more likely you are to have long lasting severe pain related to nerve damage from the virus. This risk can be almost completely eliminated by getting Shingrix®

We will give any of our established patients Shingrix®. No office charge will be made. We ask our patients to call ahead to be sure we have Shingrix® in stock and my medical assistants will administer the vaccine between 7 am and 12 noon and between 1:30 pm and 4:30 pm any day that we are open (usually Monday through Thursday). You will probably have a copay. If any of my patients does not have coverage for Shingrix®, we will give it at our cost.  This is estimated to be $138 per shot.

 

Shingles Vaccine

 

 
 
 

 

Register   |  Login